Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 5Fallopian Tube Neoplasms 4Peritoneal Neoplasms 3Hyperthermia 3Carcinoma, Ovarian Epithelial 3Recurrence 1Mesothelioma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Brenner Tumor 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Abdominal Neoplasms 1

Interventions

Oxaliplatin 4Leucovorin 4Irinotecan 4Fluorouracil 4Capecitabine 3Bevacizumab 3cobimetinib 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Panitumumab 2Magnetic Resonance Spectroscopy 2Ketamine 2Hydroxychloroquine 2Cyclophosphamide 2Cisplatin 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tivozanib 1sodium thiosulfate 1rucaparib 1romiplostim 1rilotumumab 1regorafenib 1pralsetinib 1ponatinib 1pembrolizumab 1osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gastrointestinal Neoplasms × Cytoreduction Surgical Procedures × Clear all
NCT00052962 2012-11-22

Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
30 enrolled 10 charts
Gastrointestinal

Hyperthermia, Appendiceal Neoplasms, Carcinoma, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡